Zeaxanthin is bioavailable from genetically modified zeaxanthin-rich potatoes
- 217 Downloads
The carotenoid zeaxanthin accumulates in the human macula lutea and protects retinal cells from blue light damage. However, zeaxanthin intake from food sources is low. Increasing zeaxanthin in common foods such as potatoes by traditional plant breeding or by genetic engineering could contribute to an increased intake of this carotenoid and, consequently, to a decreased risk of age-related macular degeneration. Our aim was to investigate whether zeaxanthin from genetically modified zeaxanthin-rich potatoes is bioavailable in humans. Three men participated in this randomized, controlled double-blinded, crossover pilot study. All subjects consumed 1,100 g of mashed potatoes, either genetically modified (Solanum tuberosum L. var. Baltica GM47/18; 3 mg zeaxanthin) or wild-type control potatoes (Solanum tuberosum L. var. Baltica; 0.14 mg zeaxanthin). A second treatment was followed after a 7-day wash-out period. The concentration of zeaxanthin was significantly increased in chylomicrons after consumption of genetically modified potatoes and 0.27 mg of the 3 mg zeaxanthin dose could be detected in chylomicrons. Consumption of control potatoes had no effect on concentrations of zeaxanthin in chylomicrons. After normalization of chylomicron zeaxanthin for plasma triacylglycerol, the time course of zeaxanthin concentrations peaked at 7 h after consumption of genetically modified potatoes. There were no significant differences in the concentrations of other major potato carotenoids such as lutein and β-carotene in chylomicrons after consumption of genetically modified and wild type control potatoes. Thus, consumption of zeaxanthin-rich potatoes significantly increases chylomicron zeaxanthin concentrations suggesting that potentially such potatoes could be used as an important dietary source of zeaxanthin.
Keywordszeaxanthin bioavailability age-related macular degeneration potato
The study was supported by a grant from the German Federal Ministry of Education and Research (BMBF-0312248H). We thank E Hoch, U Stadler-Prayle, and S Demirel for their excellent technical assistance. The initial idea for the project came from GR and AB. JM and AB designed and performed the intervention study and were responsible for the test meals, sample collection and storage. GW has supervised wildtype and GM potato breeding and storage. KB measured the carotenoids. AB and KB evaluated the data and drafted the manuscript. None of the authors had any conflict of interest.
- 4.Bertram B (2005) Blindheit und Sehbehinderung in Deutschland: Ursachen und Häufigkeit (Blindness and visual impairment in Germany: causes and incidence). Der Augenarzt 39:267–268Google Scholar
- 6.Briviba K, Kulling SE, Möseneder J, Watzl B, Rechkemmer G, Bub A (2004) Effects of supplementing a low-carotenoid diet with a tomato extract for 2 weeks on endogenous levels of DNA single strand breaks and immune functions in healthy nonsmokers and smokers. Carcinogenesis 25:2373–2378CrossRefGoogle Scholar
- 8.Erdman JW, Bierer TL, Gugger ET (1993) Absortion and Transport of Carotenoids. In: Canfield LM, Krinsky NI, Olson JA (eds) Carotenoids in Human Health. The New York Academy of Sciences, New York, pp 76–85Google Scholar
- 11.Gartner C, Stahl W, Sies H (1996) Preferential increase in chylomicron levels of the xanthophylls lutein and zeaxanthin compared to beta-carotene in the human. Int J Vitam Nutr Res 66:119–125Google Scholar
- 12.Guymer RH, Chong EWT (2006) Modifiable risk factors for age-related macular degeneration. Med J Aust 184:455–458Google Scholar
- 14.Hu X, Jandacek RJ, White WS (2000) Intestinal absorption of beta-carotene ingested with a meal rich in sunflower oil or beef tallow: postprandial appearance in triacylglycerol-rich lipoproteins in women. Am J Clin Nutr 71:1170–1180Google Scholar
- 15.Kirchhof B (2000) Die altersabhängige Makuladegeneration (Age-related macular degeneration). Deutsches ärzteblatt 97:A-1458–A-1462Google Scholar
- 20.Ribaya-Mereado JD, Blumberg JB (2004) Lutein and zeaxanthin and their potential roles in disease prevention. J Am Col Nutr 23:567S–587SGoogle Scholar
- 24.Sharoni Y, Danilenko M, Levy J, W Stahl (2004) Anticancer activity of carotenoids: from human studies to cellular processes and gene regulation. In: Krinsky NI, Mayne ST, Sies H (eds) Carotenoids in health and disease. Marcel Dekker, New York, pp 165–196Google Scholar
- 25.van Vliet T, Schreurs WH, van den Berg H (1995) Intestinal beta-carotene absorption and cleavage in men: response of beta-carotene and retinyl esters in the triglyceride-rich lipoprotein fraction after a single oral dose of beta-carotene. Am J Clin Nutr 62:110–116Google Scholar
- 26.Voultilainen S, Nurmi T, Mursu J, Rissanen TH (2006) Carotenoids and cardiovascular health. Am J Clin Nutr 83:1265–1271Google Scholar